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Abstract
Introduction: To assess potential metabolic and microcirculatory
alterations in critically ill patients, near-infrared spectroscopy
(NIRS) has been used, in combination with a vascular occlusion
test (VOT), for the non-invasive measurement of tissue oxygen
saturation (StO2), oxygen consumption, and microvascular reper-
fusion and reactivity. The methodologies for assessing StO2 during
a VOT, however, are very inconsistent in the literature and, conse-
quently, results vary from study to study, making data comparison
difficult and potentially inadequate. Two major aspects concerning
the inconsistent methodology are measurement site and probe
spacing. To address these issues, we investigated the effects of
probe spacing and measurement site using 15 mm and 25 mm
probe spacings on the thenar and the forearm in healthy volunteers
and quantified baseline, ischemic, reperfusion, and hyperemic
VOT-derived StO2 variables.
Methods: StO2 was non-invasively measured in the forearm and
thenar in eight healthy volunteers during 3-minute VOTs using two
InSpectra tissue spectrometers equipped with a 15 mm probe or a
25 mm probe. VOT-derived StO2 traces were analyzed for base-
line, ischemic, reperfusion, and hyperemic parameters. Data were
categorized into four groups: 15 mm probe on the forearm (F15mm),
25 mm probe on the forearm (F25mm), 15 mm probe on the thenar
(T15mm), and 25 mm probe on the thenar (T25mm).
Results: Although not apparent at baseline, probe spacing and
measurement site significantly influenced VOT-derived StO2
variables. For F15mm, F25mm, T15mm, and T25mm, StO2 downslope
was –6.4 ± 1.7%/minute, –10.0 ± 3.2%/minute, –12.5 ± 3.0%/
minute, and –36.7 ± 4.6%/minute, respectively. StO2 upslope was
105 ± 34%/minute, 158 ± 55%/minute, 226 ± 41%/minute, and
713 ± 101%/minute, and the area under the hyperemic curve was
7.4 ± 3.8%·minute, 10.1 ± 4.9%·minute, 12.6 ± 4.4%·minute, and
21.2 ± 2.7%·minute in these groups, respectively. Furthermore, the
StO2 parameters of the hyperemic phase of the VOT, such as the
area under the curve, significantly correlated to the minimum StO2
during ischemia.
Conclusions: NIRS measurements in combination with a VOT are
measurement site-dependent and probe-dependent. Whether this
dependence is anatomy-, physiology-, or perhaps technology-
related remains to be elucidated. Our study also indicated that
reactive hyperemia depends on the extent of ischemic insult.
Introduction
It is now well established that tissue oxygen utilization and
regional microcirculatory oxygen transport properties are
severely affected during sepsis and shock [1-9]. To assess
and identify these metabolic and microcirculatory alterations
non-invasively, near-infrared spectroscopy (NIRS) has
recently been applied to measure the behavior of tissue
oxygen saturation (StO2). Besides observation of steady-
state values, a vascular occlusion test (VOT) has been intro-
duced for the measurement of tissue oxygen consumption
and of microvascular reperfusion and reactivity [9-14].
The VOT seems to be sensitive to the progress and outcome
of sepsis in critical illness [9,12]. A large number of variables
exist in the performance of this maneuver, however, yielding
apparently conflicting results and uncertainty as to the
significance of the various VOT-derived StO2 parameters
[11]. The analysis, interpretation, and understanding of VOT-
derived StO2 traces, although being widely employed in
septic and trauma patients, is limited, especially for the post-
occlusion phase of the VOT. Consequently, identification of
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which StO2 parameters are most appropriate for scoring
(micro)vascular reperfusion and reactivity remains to be
determined. Proper characterization of VOT-derived StO2
parameters in health is hence needed to allow translation of
results obtained in patients to pathophysiological phenomena.
The main problem with the interpretation of StO2 data in the
literature is the diversity of methodologies used for assessing
StO2 during a VOT. Results vary from study to study, making
data comparison and interpretation difficult and possibly
inadequate. Two major aspects regarding the inconsistent
methodology are the measurement site and probe spacing
(that is, the spatial separation between the illumination and
detection fibers of the NIRS probe). The measurement site is
important because differences may exist in the sensitivity of
muscle groups and/or other anatomical structures to the VOT
during health and/or pathophysiological conditions. Probe
spacing, on the other hand, will determine the depth of
measurement within the respective muscle group. To study
the roles of both variables, we performed 3-minute VOTs in
healthy volunteers and measured StO2 using 15 mm and
25 mm probe spacings on the thenar and the forearm. VOT-
derived StO2 traces were quantified for baseline, ischemic,
reperfusion, and hyperemic StO2 parameters. We expect
these results to provide an essential frame of reference for
conducting StO2 measurements in future clinical studies.
Materials and methods
Subjects
The study protocol was approved by the Medical Ethics
Committee of the Erasmus Medical Center Rotterdam. Eight
healthy volunteers (Table 1) who were not receiving any vaso-
active medication were requested to refrain from consuming
caffeine-containing beverages prior to the experiments. The
subjects were comfortably seated in the experimental room
(mean ± standard deviation room temperature was 21 ± 1°C)
1 hour before measurements and were requested not to
perform any physical labor (for example, lifting and writing).
Near-infrared spectroscopy
StO2 was continuously and non-invasively measured using
two InSpectra tissue spectrometers (Model 325; Hutchinson
Technology, Hutchinson, MN, USA). The spectrometers use
reflectance mode probes that have a 1.5 mm optical fiber to
illuminate the tissue and a 0.4 mm optical fiber to collect the
backscattered light from the tissue. Two types of probes
were used for this study: one with 15 mm spacing between
the illumination and the collecting optical fibers, and one with
25 mm spacing. Both probes have been used in various
studies with varying results [9-12].
The relative optical attenuation of the backscattered light at
four wavelengths (680 nm, 720 nm, 760 nm, and 800 nm) is
measured to calculate two second-derivative attenuation
values, one centered at 720 nm and the other at 760 nm
[15]. The ratio of the 720 nm to 760 nm second-derivative
values is directly extrapolated to StO2, defined as [HbO2]/
([Hb] + [HbO2]), via a calibration table. The calibration table
relating StO2 to the second-derivative attenuation ratio is
stored permanently within the NIRS device and is common to
each device and probe used [15]. The NIRS devices were
calibrated before the first measurement in each subject using
a light-scatter calibrator.
Vascular occlusion test
One NIRS probe was placed on the skin of the thenar
eminence and another NIRS probe was placed on the lateral
side of the anterior surface of the forearm for simultaneous
measurement of thenar StO2 and forearm StO2 during the
VOTs. Both the hand and the forearm were kept at heart level
with the palms up. The subjects were instructed not to move
their hand or arm, or to change their sitting position during
measurements.
Baseline arterial pressure was measured using a manual
sphygmomanometer. After a 3-minute stabilization period
(baseline measurement), stagnant ischemia was induced for
3 minutes by rapidly inflating a pneumatic cuff (within
5 seconds), placed around the upper arm, to 50 mmHg above
systolic blood pressure. The cuff was subsequently deflated
(within 1 second) and StO2 measurements were continued
up to 5 minutes post ischemia.
StO2 curve characteristics
StO2 data from the two devices were continuously saved
(one sample every 3.5 seconds) on two computers and were
Table 1
Demographic characteristics of the studied subjects
Demographic characteristic Mean ± standard deviation
Age (years) 28 ± 6
Gender (%)
Female 25
Male 75
Dominant hand (%)
Right 87.5
Left 12.5
Weight (kg) 78 ± 10
Height (cm) 178 ± 8
Tympanic temperature (°C) 36.6 ± 0.5
Systolic blood pressure (mmHg) 112 ± 9
Diastolic blood pressure (mmHg) 73 ± 7
Mean arterial pressure (mmHg) 91 ± 8
Heart rate (beats/minute) 69 ± 8retrospectively analyzed using InSpectra Analysis V3.3
software (Hutchinson Technology). The VOT-derived StO2
traces were divided into four phases: baseline, ischemia,
reperfusion, and hyperemia (Figure 1).
The ischemic phase was analyzed for StO2 downslope
(%/minute), minimum StO2 after 3 minutes of ischemia (%),
and ΔStO2 (%; that is, the difference between baseline and
minimum StO2). The StO2 downslope is generally considered
to reflect muscle metabolism and the minimum StO2 is
considered to indicate the extent of ischemia.
The reperfusion phase was analyzed for two parameters:
StO2 upslope (%/minute) and rise time (minutes), both
measured over the interval from minimum StO2 to baseline
StO2 (Figure 1). Although these parameters are directly
related (StO2 upslope = ΔStO2/Rise time), the StO2 upslope
is metabolism-dependent as it is based on ΔStO2 after a fixed
time of occlusion (that is, 3 minutes), while the rise time solely
represents the time required to wash out the stagnantly
deoxygenated blood by oxygenated arterial blood during
reperfusion. These two parameters were therefore measured
and analyzed separately.
The hyperemic phase of the VOT was analyzed for peak StO2
during reperfusion (%), for StO2 overshoot (that is, difference
between peak StO2 and baseline StO2), for the area under
the hyperemic curve (AUC; %·minute), and for the settling
time from release of the cuff to recovery to baseline StO2
(minutes).
Measurement protocol
Three measurement variables were investigated and com-
pared for the assessment of VOT-derived StO2 parameters:
dominant arm versus nondominant arm, forearm versus
thenar, and superficial tissue versus deep tissue (as
measured by the different probe spacings). For this purpose,
four measurements were performed per subject: two on the
dominant side and two on the nondominant side. Although
good reproducibility of NIRS measurements during sequential
VOTs has been demonstrated by Gómez and colleagues
[11], the side and probes were switched after every VOT.
Additionally, to avoid any effect of starting conditions, the first
measurement in four subjects was performed on the
dominant side with the 15 mm probe on the forearm and the
25 mm probe on the thenar, whereas in the other four
subjects the first measurement was performed on the
nondominant side with the 15 mm probe on the thenar and
the 25 mm probe on the forearm.
Statistical analysis
First, differences between the dominant arm and the
nondominant arm were analyzed and data were subsequently
categorized into four groups: 15 mm probe on the forearm
(F15mm), 25 mm probe on the forearm (F25mm), 15 mm probe
on the thenar (T15mm), and 25 mm probe on the thenar
(T25mm). Statistical analysis was performed in GraphPad
Prism software (GraphPad Software, San Diego, CA, USA).
Normal distribution of the data within all groups (dominant,
nondominant, F15mm, F25mm, T15mm, and T25mm) was confirmed
for each StO2 parameter using the D’Agostino and Pearson
omnibus normality test. Comparative analysis between
groups was performed using analysis of variance with a
Bonferroni post-hoc test. Correlation analysis was performed
by Pearson’s analysis for normally distributed datasets. All
data are presented as the mean ± standard deviation. Differ-
ences between groups with P <0.05 were considered
statistically significant.
Results
No differences between the dominant and nondominant sides
were found and data could therefore be categorized into four
groups: F15mm, F25mm, T15mm, and T25mm. Baseline StO2 was
similar in all groups and independent of probe spacing and
measurement site: 81 ± 10% for F15mm, 85 ± 7% for F25mm,
87 ± 4% for T15mm, and 87 ± 3% for T25mm. Occlusion of the
upper arm by a pneumatic cuff resulted in an immediate
decrease in StO2. Release of the occlusion after 3 minutes
was followed by a rapid increase in StO2 and a StO2
overshoot relative to baseline. Less than 3 minutes post-
ischemia, StO2 values were restored to baseline level.
Ischemic phase
The downslopes during ischemia were measured using linear
regression analysis over the linear part (that is, R2 >0.95) of
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Figure 1
Vascular occlusion test-derived tissue oxygen saturation phases and
parameters. The vascular occlusion test-derived tissue oxygen
saturation (StO2) traces were divided into four phases (baseline,
ischemia, reperfusion, and hyperemia) and were analyzed for baseline
StO2 (BSLN), StO2 downslope, minimum StO2, StO2 upslope, rise
time, peak StO2, area under the hyperemic curve (AUC), and settling
time.the StO2 curve. For the first three groups (F15mm, F25mm, and
T15mm), the downslopes were linear over the entire 3-minute
period of ischemia. The downslopes measured in the T25mm
group, in contrast, were linear over a time interval of 2.34 ±
0.38 minutes. For F15mm, F25mm, T15mm, and T25mm, StO2 down-
slopes were –6.4 ± 1.7%/minute, –10.0 ± 3.2%/minute,
–12.5 ± 3.0%/minute, and –36.7 ± 4.6%/minute, respectively
(Figure 2). Hence, during 3 minutes of ischemia, StO2
decreased significantly (P <0.001) by 20 ± 5%, 31 ± 11%,
38 ± 9%, and 84 ± 6% for F15mm, F25mm, T15mm, and T25mm,
respectively, which resulted in a minimum StO2 of 60 ± 13%,
54 ± 16%, 49 ± 8%, and 3 ± 5% in these groups (Figure 2).
For all groups, minimum StO2 values were significantly lower
than baseline values (P  <0.001). For the downslopes and
ΔStO2 during ischemia, values for F15mm differed significantly
from values for F25mm (P <0.01), for T15mm (P <0.001), and
for T25mm (P <0.001). The minimum StO2 was significantly
higher in the F15mm group with respect to T15mm (P <0.05)
and to T25mm (P <0.001). No significant differences between
F25mm and T15mm were found for these parameters.
Downslopes,  ΔStO2, and minimum StO2 measured in the
T25mm group were significantly different from those measured
in the other groups (P <0.001).
Reperfusion phase
After release of the cuff pressure, StO2 rapidly increased to
(and above) baseline StO2. In F15mm, F25mm, T15mm, and T25mm,
StO2 rise times (that is, time from minimum StO2 to baseline
StO2) were 0.208 ± 0.062 minutes, 0.198 ± 0.050 minutes,
0.198 ± 0.042 minutes, and 0.147 ± 0.033 minutes, respec-
tively. None of these results were significantly different
between groups (Figure 3).
In contrast to the rise times, differences between the StO2
upslopes (calculated over the same interval as the rise time)
were found between groups due to differences in baselines
and minima (StO2 upslope = (StO2 baseline – StO2
minimum)/Rise time). Upslopes were 105 ± 34%/minute,
158 ± 55%/minute, 226 ± 41%/minute, and 713 ± 101%/
minute for F15mm, F25mm, T15mm, and T25mm, respectively. The
upslopes in the thenar were significantly higher than the
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Figure 2
Tissue oxygen saturation at baseline and after ischemia, and the corresponding downslopes. (a) Measured tissue oxygen saturation (StO2)
baseline values and minima after 3 minutes of ischemia. (b) Corresponding StO2 downslopes (right). ns = not significant (P >0.05), **P <0.01,
***P <0.001. F, forearm; T, thenar.
Figure 3
Measured rise times and the corresponding tissue oxygen saturation upslopes. (a) Measured rise times. (b) Corresponding tissue oxygen
saturation (StO2) upslopes. *P <0.05, **P <0.01, ***P <0.001. F, forearm; T, thenar.upslopes in the forearm, and the upslopes measured with the
25 mm probe were significantly higher than those measured
with the 15 mm probe (Figure 3).
Although the rise time and StO2 upslope both describe
(micro)vascular reperfusion following ischemia, apparently
these parameters are sensitive to different variables. Hence,
where the rise time is similar for the forearm and the thenar
and is independent of the applied probe, the StO2 upslope
depends significantly on both the muscle and the probe type.
Hyperemic phase
Peak StO2 following release of the upper arm occlusion was
88 ± 7%, 93 ± 5%, 95 ± 3%, and 98 ± 0% for F15mm, F25mm,
T15mm, and T25mm, respectively, Only the peak in the F15mm
group differed significantly from the thenar (P <0.001 with
respect to T15mm and T25mm). No significant differences were
found for the StO2 overshoot (that is, peak StO2 – Baseline
StO2): 6.9 ± 3.8%, 8.6 ± 3.7%, 8.7 ± 3.2%, and 11.3 ± 2.7%
for F15mm, F25mm, T15mm, and T25mm, respectively.
The settling time, defined as the time required for the StO2 to
completely restore to baseline (Figure 4), was 2.170 ± 0.511
minutes, 1.950 ± 0.475 minutes, 2.588 ± 0.306 minutes,
and 2.755 ± 0.360 minutes for F15mm, F25mm, T15mm, and
T25mm, respectively. No significant differences were found
with respect to the probe spacing (that is, F15mm versus F25mm
(P >0.05) and T15mm versus T25mm (P >0.05)), but significant
differences existed between measurement sites (that is,
F15mm versus T15mm and T25mm (P <0.05), and F25mm versus
T15mm and T25mm (P <0.01)).
The AUC was 7.4 ± 3.8%·minute, 10.1 ± 4.9%·minute,
12.6 ± 4.4%·minute, and 21.2 ± 2.7%·minute for F15mm, F25mm,
T15mm, and T25mm, respectively (Figure 4). No significant
differences were found between the 15 mm probe and the
25 mm probe on the forearm. Using the 15 mm probe, the
AUC in the thenar was significantly higher (P <0.01) than in
the forearm. AUCs measured in the T25mm group were
significantly higher than those measured in the other groups
(P <0.001).
Correlation analysis
To investigate the relationship between the extent of ischemia
and the StO2 parameters of reperfusion and hyperemia,
correlation analysis (Pearson’s analysis) was performed for
minimum StO2 versus reperfusion parameters (StO2 upslope
and rise time) and hyperemic parameters (peak StO2, StO2
overshoot, AUC, and settling time) from combined data of
F15mm, F25mm, and T15mm. T25mm data were excluded from the
analysis because StO2 downslopes were not linear over the
entire 3-minute period of ischemia, which would affect the
consistency in the correlation analysis.
StO2 upslope correlated significantly with minimum StO2
(r = 0.81, P  <0.001), while the rise time did not (r = 0.12,
P >0.05). The peak StO2 (r = 0.3, P <0.05), StO2 overshoot
(r = 0.44, P <0.001), and AUC (r = 0.45, P <0.01) exhibited
a weak positive correlation with minimum StO2, whereas a
correlation was absent with respect to settling time (r = 0.16,
P >0.05).
To illustrate why the rise time and StO2 upslope behave
differently in relation to the measurement site and probe
spacing, two individual measurements are described in detail.
One measurement was performed with the 15 mm probe on
the forearm and the other with the 15 mm probe on the
thenar, both with a baseline StO2 of 88%. The StO2
downslope during ischemia was –8%/minute in the forearm
and –16%/minute in the thenar. This resulted in different
StO2 minima for the two curves: 64% in the forearm and
40% in the thenar. After release of the occlusion, both curves
restored back to their baseline level in 0.233 minutes. The
rise times, and thus the reperfusion dynamics, for both curves
were therefore equal. The StO2 upslopes, in contrast, were
very different: 103%/minute in the forearm and 206%/minute
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Figure 4
Measured settling times and the corresponding areas under the hyperemic curves. (a) Measured settling times. (b) Corresponding areas under the
curves. ns = not significant (P >0.05), *P <0.05, **P <0.01, ***P <0.001. F, forearm; T, thenar.in the thenar. This suggests that the StO2 upslope does not
solely reflect post-ischemia reperfusion dynamics, but is also
strongly influenced by the extent of StO2 decrease during
ischemia.
Discussion
The primary finding of this study was that, although not
apparent at baseline, the probe spacing and measurement
site significantly influenced VOT-derived StO2 variables. The
StO2 upslope in the reperfusion phase of the VOT was
shown to depend on the minimum StO2 after 3 minutes of
ischemia, while the rise time was not. Furthermore, the StO2
parameters of the hyperemic phase of the VOT were shown
to significantly correlate to the minimum StO2 value after
3 minutes of ischemia.
Among the investigations employing a NIRS device identical
to the ones used in the present study, some studies have
used 15 mm probe spacing [10,11,14] while others have
used 25 mm probe spacing [9,12,16-18]. In healthy
volunteers, all of these studies – including ours – have shown
that baseline StO2 values were similar, independent of the
applied probe. The VOT-derived StO2 variables as reported
in the literature, however, varied widely between the studies
using a 15 mm probe and the studies using a 25 mm probe
[9-12,14,16-18]. The values obtained in the present study
are comparable to those obtained in the above-referenced
studies. In the present study we quantitatively compared the
VOT-derived StO2 variables obtained using both probes and
confirmed the hypothesis that this difference in StO2
downslopes is indeed caused by the use of different probe
spacings. In the thenar, the 15 mm probe provided a longer
time interval of linear StO2 decay during ischemia than the
25 mm probe, which could make the estimation of the
ischemic insult and muscle metabolism inaccurate and
possibly inadequate when using the 25 mm probe.
The potential mechanisms by which the VOT-derived StO2
traces might be different when measured by the 15 mm or
25 mm probes could be anatomy-related, physiology-related,
or even technology-related. It is well established that muscle
cells consume much more oxygen per unit time compared
with skin and adipose tissue. Additionally, if the ischemic
stimulus is more extensive in the muscle compared to the
more superficial layer of (sub)dermal tissue, the reactive
hyperemia is probably also of a larger extent in the deeper,
muscular, layer. In this light, the probe dependence, and thus
the measurement depth dependence, of the StO2 downslope
and hyperemic parameters could therefore be explained by
variable relative contributions of (sub)dermal tissue and
muscular tissue to the NIRS signal for the different probing
depths. Another option that might explain the probe
dependence of the StO2 traces, however, is that the number
of photons that reach the detection fiber of the NIRS probe
decreases with increasing probe spacing, which, in turn,
could decrease the accuracy of the StO2 calculation. This
could be especially true at low microcirculatory oxygenation,
as occurs during ischemia, where the optical absorbance of
blood is much higher compared to at high oxygenation. This,
however, is purely suggestive and no evidential data are
present to support this speculation.
In the present article we provide a frame of reference for
comparison of data measured in the thenar and forearm using
the 15 mm probe and the 25 mm probe for a very broad
spectrum of VOT-derived StO2 parameters; that is, baseline
parameters, ischemic parameters, reperfusion parameters,
and hyperemic parameters.
An important conceptual issue that is addressed in the
present study is the difference between StO2 upslope and
the rise time in the reperfusion phase of the VOT. First, it was
shown that StO2 upslopes were different between the
experimental groups while rise times were similar in these
groups. Second, the correlation analysis performed on the
minimum StO2 values after 3 minutes of ischemia versus the
StO2 upslopes and rise times showed that the StO2 upslope
correlated significantly with the minimum StO2 while the rise
time did not. From a physiological point of view, the rise time
represents the time it takes to wash out (or replace) the
stagnantly deoxygenated blood in the measurement volume
of the NIRS probe by oxygenated arterial blood. The StO2
upslope, on the other hand, has no single physiological
meaning as it is the product of multiple variables, such as the
baseline StO2, minimum StO2, and rise time. Hence, the use
of rise time seems to be a more representative measure of
(micro)vascular reperfusion than StO2 upslope.
Another pertinent result from the correlation analysis was the
significant positive correlation between the hyperemic
parameters and the minimum StO2, indicating that the extent
of hyperemia is related to the extent of ischemia. This
suggests that the use of a target or threshold StO2 might be
more appropriate for standardization of the hyperemic phase
of the VOT. After 3 minutes of ischemia, however, StO2
decreased to a minimum of 60% in the forearm and 49% in
the thenar when one uses the 15 mm probe and to 54% in
the forearm and 1% in the thenar if one uses the 25 mm
probe. The probe type should therefore be taken into account
when one uses a defined StO2 threshold value of 30 or 40%.
Moreover, the occlusion time might exceed 3 minutes when
using the 15 mm probe, which could be uncomfortable for
the studied subject.
Conclusively, the data from this study support the hypothesis
that the NIRS measurements in combination with a VOT are
measurement site-dependent and probe-dependent. The
present study showed that the use of StO2 upslope is
sensitive to the minimum StO2 after 3 minutes of ischemia
and does not solely reflect the (micro)vascular reperfusion
rate. Although the rise time seems a better measure for
(micro)vascular reperfusion following ischemia, this study
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Page 6 of 7
(page number not for citation purposes)could not determine whether the use of the rise time can
distinguish healthy (micro)vasculature from nonhealthy
(micro)vasculature. Our study also indicated that reactive
hyperemia depends on the extent of ischemic insult and
supports the use of a target StO2 over the use of a fixed time
of occlusion for a metabolism-independent analysis of
(micro)vascular reactivity, whereby the type of probe should
be taken into account. Whether the observed measurement
site dependence and probe dependence is anatomy-related,
physiology-related, or perhaps technology-related remains to
be elucidated.
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